| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
The First Department of Internal Medicine (T.A., I.M., A.K., O.I., K.Z., Y.T., S.E.), University of Occupational and Environmental Health, Japan, School of Medicine, Kitakyushu, Japan; and Ito Hospital (N.I., Ku.I., Ko.I.), Tokyo, 150-8308, Japan
Address correspondence and requests for reprints to: Isao Morimoto, The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, School of Medicine, 11 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.
Graves disease (GD) is an autoimmune thyroid disease characterized by
infiltration of lymphocytes into the thyroid, and intrathyroid
lymphocytes are known to play an important role in the pathogenesis of
GD. However, it remains to be understood how lymphocytes adhere to
thyrocytes and regulate the thyrocyte function through cellular
adhesion. We studied the mechanisms of T cell adhesion to thyrocytes
using intrathyroid mononuclear cells (ITMC) and thyrocytes purified
from the thyroids of patients with GD. The following novel features of
cellular adhesion of ITMC to thyrocytes in the regulation of the
thyrocyte function in GD were observed: 1) GD-ITMC expressed lymphocyte
function-associated antigen (LFA)-1, which became an active adhesive
configuration much higher than peripheral blood mononuclear cells
(PBMC) from normal volunteers and GD patients; 2) GD-thyrocytes
expressed a high quantity of intercellular adhesion molecule (ICAM)-1;
3) GD-ITMC adhered to GD-thyrocytes, whereas normal PBMC required
activation stimuli by phorbol myriacetate, a pharmacological
integrin-trigger, to adhere to GD- thyrocytes; 4) monoclonal
antibody-blocking studies showed that the adhesion of the activated
PBMC and ITMC to thyrocytes was mainly mediated by the LFA-1/ICAM-1
pathway; 5) the adhesion of GD-thyrocytes to the activated-PBMC or ITMC
induced the proliferation of the thyrocytes, which was blocked by the
addition of ICAM-1 and/or LFA-1 monoclonal antibodies; and 6) in GD
thyrocytes of early cultures, ICAM-1 expression on GD-thyrocytes and
its adhesion to LFA-1 on phorbol myriacetate-activated PBMC or ITMC
were not modulated by the addition of interleukin-1ß or
interferon-
, and proliferation of thyrocytes by the cellular
adhesion via the ICAM-1/LFA-1 pathway was independent of the
proliferative response of these cytokines. Taken together, these
results suggest that lymphocytes infiltrating GD thyroid induce
proliferation of GD-thyrocyte by the cellular adhesion to thyrocytes
via ICAM-1/LFA-1, which may lead to the development of a goiter.
This article has been cited by other articles:
![]() |
D. Peer, P. Zhu, C. V. Carman, J. Lieberman, and M. Shimaoka Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 PNAS, March 6, 2007; 104(10): 4095 - 4100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Gianoukakis, R. S. Douglas, C. S. King, W. W. Cruikshank, and T. J. Smith Immunoglobulin G from Patients with Graves' Disease Induces Interleukin-16 and RANTES Expression in Cultured Human Thyrocytes: A Putative Mechanism for T-Cell Infiltration of the Thyroid in Autoimmune Disease Endocrinology, April 1, 2006; 147(4): 1941 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Drexhage Are There More than Antibodies to the Thyroid-Stimulating Hormone Receptor that Meet the Eye in Graves' Disease? Endocrinology, January 1, 2006; 147(1): 9 - 12. [Full Text] [PDF] |
||||
![]() |
A. Kretowski, N. Wawrusiewicz, K. Mironczuk, J. Mysliwiec, M. Kretowska, and I. Kinalska Intercellular Adhesion Molecule 1 Gene Polymorphisms in Graves' Disease J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4945 - 4949. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression Endocrinology, July 1, 2003; 144(7): 2856 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jin and J. Li Dynamitin Controls beta 2 Integrin Avidity by Modulating Cytoskeletal Constraint on Integrin Molecules J. Biol. Chem., August 30, 2002; 277(36): 32963 - 32969. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |